Indofarma Tbk - Asset Resilience Ratio

Latest as of September 2023: 16.37%

Indofarma Tbk (INAF) has an Asset Resilience Ratio of 16.37% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Explore Indofarma Tbk long-term investment intensity to see how much of total assets are deployed in long-term investments.

Liquid Assets

Rp244.05 Billion

≈ $14.30 Million USD Cash + Short-term Investments

Total Assets

Rp1.49 Trillion

≈ $87.37 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2022)

This chart shows how Indofarma Tbk's Asset Resilience Ratio has changed over time. See Indofarma Tbk defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets Composition Over Time

This chart breaks down Indofarma Tbk's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see INAF asset base.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rp209.05 Billion	14.02%
Short-term Investments	Rp35.00 Billion	2.35%
Total Liquid Assets	Rp244.05 Billion	16.37%

Asset Resilience Insights

Good Liquidity Position: Indofarma Tbk maintains a healthy 16.37% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Indofarma Tbk Industry Peers by Asset Resilience Ratio

Compare Indofarma Tbk's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Krka d. d WAR:KRK	Drug Manufacturers - Specialty & Generic	11.18%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Jilin Aodong Pharmaceutical Group Co Ltd SHE:000623	Drug Manufacturers - Specialty & Generic	4.97%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Guangdong Taienkang Pharmaceutical Co. Ltd SHE:301263	Drug Manufacturers - Specialty & Generic	6.08%
Tianjin Ringpu Bio Tech SHE:300119	Drug Manufacturers - Specialty & Generic	14.27%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%

Annual Asset Resilience Ratio for Indofarma Tbk (2000–2022)

The table below shows the annual Asset Resilience Ratio data for Indofarma Tbk.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	20.04%	Rp307.44 Billion ≈ $18.01 Million	Rp1.53 Trillion ≈ $89.89 Million	+1.29pp
2021-12-31	18.76%	Rp377.34 Billion ≈ $22.11 Million	Rp2.01 Trillion ≈ $117.89 Million	+13.87pp
2020-12-31	4.88%	Rp83.65 Billion ≈ $4.90 Million	Rp1.71 Trillion ≈ $100.39 Million	+5.86pp
2019-12-31	-0.98%	Rp-13.57 Billion ≈ $-795.26K	Rp1.38 Trillion ≈ $81.09 Million	-0.03pp
2018-12-31	-0.95%	Rp-13.76 Billion ≈ $-806.07K	Rp1.44 Trillion ≈ $84.52 Million	-0.04pp
2017-12-31	-0.91%	Rp-13.93 Billion ≈ $-816.30K	Rp1.53 Trillion ≈ $89.64 Million	+0.11pp
2016-12-31	-1.02%	Rp-14.11 Billion ≈ $-826.88K	Rp1.38 Trillion ≈ $80.96 Million	-0.09pp
2015-12-31	-0.93%	Rp-14.29 Billion ≈ $-837.45K	Rp1.53 Trillion ≈ $89.87 Million	-0.93pp
2011-12-31	0.00%	Rp28.00 Million ≈ $1.64K	Rp1.11 Trillion ≈ $65.33 Million	0.00pp
2010-12-31	0.00%	Rp30.50 Million ≈ $1.79K	Rp733.96 Billion ≈ $43.01 Million	+0.00pp
2009-12-31	0.00%	Rp25.00 Million ≈ $1.46K	Rp728.03 Billion ≈ $42.66 Million	+0.00pp
2008-12-31	0.00%	Rp25.00 Million ≈ $1.46K	Rp965.81 Billion ≈ $56.59 Million	-0.23pp
2007-12-31	0.23%	Rp2.34 Billion ≈ $136.88K	Rp1.01 Trillion ≈ $59.15 Million	-0.99pp
2006-12-31	1.22%	Rp8.39 Billion ≈ $491.33K	Rp686.94 Billion ≈ $40.25 Million	-0.72pp
2005-12-31	1.94%	Rp10.08 Billion ≈ $590.68K	Rp518.82 Billion ≈ $30.40 Million	-5.71pp
2004-12-31	7.65%	Rp40.08 Billion ≈ $2.35 Million	Rp523.92 Billion ≈ $30.70 Million	+3.17pp
2003-12-31	4.48%	Rp28.50 Billion ≈ $1.67 Million	Rp635.96 Billion ≈ $37.26 Million	-0.51pp
2002-12-31	4.99%	Rp40.44 Billion ≈ $2.37 Million	Rp810.03 Billion ≈ $47.46 Million	-1.40pp
2001-12-31	6.39%	Rp51.89 Billion ≈ $3.04 Million	Rp811.62 Billion ≈ $47.56 Million	-3.24pp
2000-12-31	9.63%	Rp51.85 Billion ≈ $3.04 Million	Rp538.17 Billion ≈ $31.53 Million	--

pp = percentage points

About Indofarma Tbk

JK:INAF Indonesia Drug Manufacturers - Specialty & Generic

Market Cap

$22.88 Million

Rp390.51 Billion IDR

Market Cap Rank

#24675 Global

#515 in Indonesia

Share Price

Rp126.00

Change (1 day)

+0.00%

52-Week Range

Rp126.00 - Rp126.00

All Time High

Rp6975.00